5-ASA Agents
(5-aminosalicylic acid)
These are drugs in the sulfasalazine, mesalazine, and mesalamine classes, available in the form of oral medications, suppositories, and enemas.
Initially developed as arthritis treatments, their efficacy for inflammatory bowel diseases such as ulcerative colitis and Crohn's disease was discovered. Since then, they have become widely established as the foundational drugs for ulcerative colitis and Crohn's disease.
Characteristics and Limitations:
The exact mechanism by which these drugs are effective for ulcerative colitis or Crohn's disease is not clearly understood, and they are widely used in mild initial stages without knowing the exact mechanism of action. In cases of early ulcerative colitis, remission may be induced for about 1-2 years upon initial intake, but generally, relapse occurs after 1-2 years even with continued use. After a relapse, even increasing the dosage often fails to re-induce remission.